USP Final Formulary Guidelines Drop Combo HIV Drug Class At CMS’ Request

U.S. Pharmacopeia's final model guidelines for Part D formularies include a higher number of pharmacologic classes for 2008 than they did in 2007, although the proposed addition of combination anti-HIV agents as a class did not make the final cut